STOK Stoke Therapeutics, Inc.
Biotechnology NasdaqGS
Trading Signals (STOK)
Overall Signal
SELL
Strong sellish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $9.82
- Medium Support $10.37
- Weak Support $10.93
Resistance Levels
- Weak Resistance $12.04
- Medium Resistance $12.59
- Strong Resistance $13.14
Stop Loss Suggestions
- Conservative $12.05
- Moderate $12.31
- Aggressive $12.87
Analyst Ratings
Current Rating
Last Month
2 Months Ago
3 Months Ago
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | NEUTRAL |
|
Short & Medium Term |
| Oscillators | BUY |
|
Short Term |
| Trend Indicators | BUY |
|
Medium Term |
| Volume Indicators | SELL |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (STOK)
Quarterly Outlook :
2025-07-07
Bullish Scenario
from current 30.05%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (14.89) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (57.70) is in bullish territory, indicating upward momentum. MACD line (0.25) is above Signal line (-0.22) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.38, indicating the average weekly price range.
2025-07-07
Base Scenario
from current 7.21%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (14.89) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (57.70) is in bullish territory, indicating upward momentum. MACD line (0.25) is above Signal line (-0.22) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.38, indicating the average weekly price range.
2025-07-07
Bearish Scenario
from current -24.04%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (14.89) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (57.70) is in bullish territory, indicating upward momentum. MACD line (0.25) is above Signal line (-0.22) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.38, indicating the average weekly price range.
Annual Outlook
2025-07-07
Bullish Scenario
from current 60.1%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (14.89) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (57.70) is in bullish territory, indicating upward momentum. MACD line (0.25) is above Signal line (-0.22) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.38, indicating the average weekly price range.
2025-07-07
Base Scenario
from current 14.43%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (14.89) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (57.70) is in bullish territory, indicating upward momentum. MACD line (0.25) is above Signal line (-0.22) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.38, indicating the average weekly price range.
2025-07-07
Bearish Scenario
from current -48.08%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (14.89) indicates a weak or ranging trend. Market is likely in a consolidation or range-bound phase. RSI (57.70) is in bullish territory, indicating upward momentum. MACD line (0.25) is above Signal line (-0.22) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.38, indicating the average weekly price range.
Technical Analysis (STOK)
Trend Identification
EMA
Exponential Moving Average
Current price (11.48) is between Short MA (11.51) and Long MA (9.87), or near one of them. This suggests consolidation or mixed signals. Short MA (11.51) is above Long MA (9.87), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. MAs (11.51, 9.87, 9.21) show mixed alignment, suggesting market indecision or range-bound activity. Market is in a choppy or sideways phase. Wait for a clearer trend to emerge before taking directional trades.
MACD
Moving Average Convergence Divergence
MACD line is below the Signal line (bearish crossover). This indicates downward momentum. Histogram (-0.1000) is negative and expanding, confirming bearish momentum. Both MACD and Signal lines are above the zero line, reinforcing bullish momentum (bullish territory). A bearish crossover above the zero line can indicate a reversal from a prior uptrend. Consider this as a potential early sell signal.
ADX
Average Directional Index
ADX (38.35) indicates a strong trend is present. +DI (24.51) is above -DI (10.81), suggesting a bullish directional bias. This combination points to a strong upward trend. Consider taking long positions, as the strong upward trend is confirmed.
Momentum Measurement
RSI (2025-07-07)
Relative Strength Index
RSI (57.96) is in the bullish territory, but not yet overbought. This indicates upward momentum. Monitor for continuation or signs of weakness.
OBV (2025-07-07)
On-Balance Volume
OBV (1321374.00) is falling, indicating selling pressure and distribution. Price is falling and OBV is falling. This is bearish confirmation, indicating selling pressure supports the price decrease. Consider holding short positions or initiating new ones. Volume is supporting the trend.
Stochastic (2025-07-07)
Stochastic Oscillator
Stochastics (%K: 39.72, %D: 38.00) are in the neutral zone (between 20 and 80). No clear bullish or bearish crossover signal currently. The lines are close or moving sideways.
CCI (2025-07-07)
Commodity Channel Index
CCI (-122.56) is below -100. This suggests a strong downward momentum and an oversold condition. Consider buying or looking for long entries cautiously. Confirm with price action; if price is making lower lows, momentum is strong. Look for rallies to enter short.
Volatility Measurement
ATR (2025-07-07)
Average True Range
Current ATR is 0.5400. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2025-07-07)
Volatility Bands
Current price (11.48) is within the Bollinger Bands (11.04 - 11.99). This suggests the price is trading within its typical volatility range. Price is below the Middle Band (11.51), indicating short-term bearish bias.
Risk Management & Potential Reversals (STOK)
SAR (2025-07-07)
Parabolic Stop and Reverse
SAR points above price indicate bearish trend. Current SAR at 12.05 is 4.97% from price. Consider SAR as a potential take-profit level or to confirm a downtrend.
Stochastic (2025-07-07)
Neutral
Stochastic is in neutral territory (39.7). No clear overbought/oversold signal.
RSI (2025-07-07)
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2025-07-07)
Reversal Perspective
Bands show normal bandwidth. Price is in the middle of bands with normal bandwidth. No indication of imminent volatility expansion or reversal.
Holder List Top 20 (STOK)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Skorpios Trust | INSTITUTIONAL | 6906181 | 12.65% | 2025-03-31 |
| Blackrock Inc. | INSTITUTIONAL | 5862436 | 10.74% | 2025-03-31 |
| Lynx1 Capital Management Lp | INSTITUTIONAL | 5291929 | 9.69% | 2025-03-31 |
| RTW Investments LP | INSTITUTIONAL | 5123525 | 9.38% | 2025-03-31 |
| Baker Bros. Advisors, LP | INSTITUTIONAL | 4633838 | 8.49% | 2025-03-31 |
| Redmile Group, LLC | INSTITUTIONAL | 4485981 | 8.22% | 2025-03-31 |
| Morgan Stanley | INSTITUTIONAL | 3590825 | 6.58% | 2025-03-31 |
| Toronto Dominion Bank | INSTITUTIONAL | 3173258 | 5.81% | 2025-03-31 |
| Vanguard Group Inc | INSTITUTIONAL | 2784202 | 5.1% | 2025-03-31 |
| FMR, LLC | INSTITUTIONAL | 2541937 | 4.66% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 1574196 | 2.88% | 2025-03-31 |
| Fidelity Select Portfolios-Biotechnology Portfolio | MUTUALFUND | 1045713 | 1.92% | 2025-04-30 |
| Fidelity Select Portfolios-Health Care Portfolio | MUTUALFUND | 1000000 | 1.83% | 2025-04-30 |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | MUTUALFUND | 972100 | 1.78% | 2025-04-30 |
| BlackRock Funds-BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO | MUTUALFUND | 925936 | 1.7% | 2025-02-28 |
| iShares Trust-iShares Russell 2000 ETF | MUTUALFUND | 888355 | 1.63% | 2025-04-30 |
| Fidelity Securities Fund-Fidelity Series Small Cap Opportunities Fund | MUTUALFUND | 836300 | 1.53% | 2025-04-30 |
| SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF | MUTUALFUND | 737648 | 1.35% | 2025-04-30 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | MUTUALFUND | 612448 | 1.12% | 2025-03-31 |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | MUTUALFUND | 600000 | 1.1% | 2025-04-30 |